Back | Next |
home / stock / ogen / ogen message board
Subject | By | Source | When |
---|---|---|---|
Qiagen has received emergency use authorization from the | retired early | investorshub | 08/06/2021 5:28:47 PM |
$OGEN will be a player....opportunity knocks. | oakrock | investorshub | 07/28/2021 10:37:21 PM |
Been a nice atm. | GREGG THE GREEK | investorshub | 07/28/2021 1:16:12 PM |
What will happen today? Morning dip into low | Lowhndcpr | investorshub | 07/28/2021 1:02:49 PM |
Here comes eod volume | MADDSTACKER | investorshub | 07/27/2021 6:43:39 PM |
$100-$200M from Canadian govt funding ? | shurtha2000 | investorshub | 07/27/2021 3:07:23 PM |
Should thin out soon | MADDSTACKER | investorshub | 07/27/2021 2:57:35 PM |
EPIC :) | retired early | investorshub | 07/27/2021 1:36:20 PM |
Could be epic | MADDSTACKER | investorshub | 07/27/2021 12:46:59 PM |
Big day looming here after $OGEN announcement of | bigbut | investorshub | 07/27/2021 12:19:57 PM |
Nice day here. Need to get back to | Lowhndcpr | investorshub | 07/19/2021 8:05:10 PM |
O-0 | 420man | investorshub | 06/07/2021 10:48:12 PM |
$OGEN cover time :-) | dancy | investorshub | 05/18/2021 6:32:53 PM |
* * $OGEN Video Chart 04-23-2021 * * | ClayTrader | investorshub | 04/23/2021 10:38:01 PM |
It's all about the therapeutics, peutics, peutics. :) | retired early | investorshub | 04/23/2021 4:14:33 PM |
It's time for the CEO to get his | trendzone | investorshub | 04/09/2021 5:45:39 PM |
Past time.................But I can wait. | DMOST | investorshub | 04/09/2021 8:07:38 AM |
Time to.move up | oxnous | investorshub | 04/09/2021 1:24:03 AM |
Sorry, spike.... | Golden Cross | investorshub | 04/07/2021 12:53:20 AM |
$OGEN Meandering up from the morning low on | geocam | investorshub | 03/30/2021 8:40:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) dated April ...
Oragenics, Inc. (the “Company”) (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it has filed its annual report on March 29, 2024. The Company is pleased to report it has execu...
Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced it has appointed Dr. James “Jim” Kelly, Neurologist, as its Chief Medical Officer, to oversee its upcoming Phase II ...